Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance studyDavid J Dabbs, Molly E Klein, Syed K Mohsin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2009
Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexaDavid W Bahler, Philippe Szankasi, Sucheta Kulkarni, et al.
The American Journal of Surgical Pathology|March 15, 2014
Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative studyJames R Cook, Bryan Goldman, Raymond R Tubbs, et al.
Annals of Diagnostic Pathology|March 24, 2009
Osteoclastlike giant cell tumor of the salivary glandXueping Fang, David G Hicks, Wesley Hicks, et al.
Journal of Cutaneous Pathology|April 25, 2006
t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomasNicholas T Wongchaowart, Bong Kim, Eric D Hsi, et al.
Journal of Cutaneous Pathology|December 17, 2013
Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcomaJennifer S Ko, Steven D Billings, Christopher P Lanigan, et al.
American Journal of Clinical Pathology|September 14, 2021
HER2-Low Breast CancersHuina Zhang, Hani Katerji, Bradley M Turner, et al.
American Journal of Clinical Pathology|April 22, 2006
Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysisGurunathan Murugesan, Samer Aboudola, Hadrian Szpurka, et al.
Pageof 22